Hypoxic mesenchymal stem cell-derived exosomes promote the survival of skin flaps after ischaemia–reperfusion injury via mTOR/ULK1/FUNDC1 pathways
Open Access
- 21 September 2023
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 21 (1) , 1-23
Abstract
Flap necrosis, the most prevalent postoperative complication of reconstructive surgery, is significantly associated with ischaemia–reperfusion injury. Recent research indicates that exosomes derived from bone marrow mesenchymal stem cells (BMSCs) hold potential therapeutic applications in several diseases. Traditionally, BMSCs are cultured under normoxic conditions, a setting that diverges from their physiological hypoxic environment in vivo. Consequently, we propose a method involving the hypoxic preconditioning of BMSCs, aimed at exploring the function and the specific mechanisms of their exosomes in ischaemia–reperfusion skin flaps. This study constructed a 3 × 6 cm2 caudal superficial epigastric skin flap model and subjected it to ischaemic conditions for 6 h. Our findings reveal that exosomes from hypoxia-pretreated BMSCs significantly promoted flap survival, decrease MCP-1, IL-1β, and IL-6 levels in ischaemia–reperfusion injured flap, and reduce oxidative stress injury and apoptosis. Moreover, results indicated that Hypo-Exo provides protection to vascular endothelial cells from ischaemia–reperfusion injury both in vivo and in vitro. Through high-throughput sequencing and bioinformatics analysis, we further compared the differential miRNA expression profiles between Hypo-Exo and normoxic exosomes. Results display the enrichment of several pathways, including autophagy and mTOR. We have also elucidated a mechanism wherein Hypo-Exo promotes the survival of ischaemia–reperfusion injured flaps. This mechanism involves carrying large amounts of miR-421-3p, which target and regulate mTOR, thereby upregulating the expression of phosphorylated ULK1 and FUNDC1, and subsequently further activating autophagy. In summary, hypoxic preconditioning constitutes an effective and promising method for optimizing the therapeutic effects of BMSC-derived exosomes in the treatment of flap ischaemia–reperfusion injury.Keywords
Funding Information
- National Natural Science Foundation of China (82072194, 81871577)
This publication has 65 references indexed in Scilit:
- Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagyNature Medicine, 2013
- Update on Ischemia-Reperfusion Injury for the Plastic SurgeonPlastic and Reconstructive Surgery, 2011
- Activation of autophagy in mesenchymal stem cells provides tumor stromal supportCarcinogenesis, 2011
- Mechanisms of mitophagyNature Reviews Molecular Cell Biology, 2010
- Autophagy fights disease through cellular self-digestionNature, 2008
- Hematopoietic Stem-Cell TransplantationNew England Journal of Medicine, 2006
- The protective effect of melatonin on ischemia–reperfusion injury in the groin (inferior epigastric) flap model in ratsJournal of Pineal Research, 2006
- Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAsNature Reviews Genetics, 2004
- GβL, a Positive Regulator of the Rapamycin-Sensitive Pathway Required for the Nutrient-Sensitive Interaction between Raptor and mTORMolecular Cell, 2003
- Reperfusion Injury and Oxygen Free Radicals: A ReviewJournal of Reconstructive Microsurgery, 1989